Skip to main content
Journal ArticleOPEN ACCESS

Development of SMTP, a prothrombolytic and anti-inflammatory small molecule, for the treatment of ischemic stroke

  • HASUMI K
Japanese Journal of Thrombosis and Hemostasis (2021) 32(3) 278-283
DOI: 10.2491/jjsth.32.278
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

HASUMI, K. (2021). Development of SMTP, a prothrombolytic and anti-inflammatory small molecule, for the treatment of ischemic stroke. Japanese Journal of Thrombosis and Hemostasis, 32(3), 278–283. https://doi.org/10.2491/jjsth.32.278

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free